Biodexa Pharmaceuticals Plc (BDRX)
1.32
-0.19
(-12.58%)
USD |
NASDAQ |
May 01, 16:00
1.32
0.00 (0.00%)
Pre-Market: 08:06
Biodexa Pharmaceuticals Cash and Short Term Investments (Quarterly): 7.606M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.606M |
| June 30, 2023 | 6.593M |
| June 30, 2023 | 6.593M |
| December 31, 2022 | 3.432M |
| June 30, 2022 | 7.790M |
| June 30, 2022 | 7.790M |
| December 31, 2021 | 13.57M |
| June 30, 2021 | 5.818M |
| June 30, 2021 | 5.818M |
| December 31, 2020 | 10.28M |
| June 30, 2020 | 5.327M |
| June 30, 2020 | 5.327M |
| December 31, 2019 | 14.33M |
| June 30, 2019 | 11.38M |
| Date | Value |
|---|---|
| June 30, 2019 | 11.38M |
| December 31, 2018 | 2.973M |
| June 30, 2018 | 5.382M |
| June 30, 2018 | 5.382M |
| December 31, 2017 | 17.84M |
| June 30, 2017 | 8.047M |
| June 30, 2017 | 8.047M |
| December 31, 2016 | 21.63M |
| June 30, 2016 | 9.727M |
| June 30, 2016 | 9.727M |
| December 31, 2015 | 23.96M |
| June 30, 2015 | 38.28M |
| June 30, 2015 | 38.28M |
| December 31, 2014 | 47.20M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
3.432M
Minimum
Dec 2022
14.33M
Maximum
Dec 2019
8.202M
Average
7.606M
Median
Dec 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 146.94M |
| NuCana PLC | 21.94M |
| Autolus Therapeutics PLC | 239.57M |
| Mereo BioPharma Group PLC | 57.42M |
| Bicycle Therapeutics PLC | 526.42M |